Kamei J, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Hoshi University, Tokyo, Japan.
Eur J Pharmacol. 1993 Mar 30;234(1):117-20. doi: 10.1016/0014-2999(93)90714-s.
We examined the effect of [D-Ala2]deltorphin II, a selective delta 2-opioid receptor agonist, on the antitussive effect of [D-Ala2, MePhe4,Gly-ol5]enkephalin (DAMGO), a selective mu-opioid receptor agonist. [D-Ala2]deltorphin (3 nmol i.c.v.) had no significant effect on the number of coughs. However, upon i.c.v. pretreatment with [D-Ala2]deltorphin II (3 nmol) the antitussive activity of DAMGO (0.03 nmol) was significantly enhanced. The enhancement of the antitussive activity of DAMGO caused by [D-Ala2]deltorphin II was prevented by a benzofuran derivative of naltrindole (0.1 mg/kg s.c.), a selective delta 2-opioid receptor antagonist. These results suggest that delta 2-opioid receptors may play a synergistic role in antitussive processes that are mediated by mu-opioid receptors.
我们研究了选择性δ2-阿片受体激动剂[D-Ala2]强啡肽II对选择性μ-阿片受体激动剂[D-Ala2,MePhe4,Gly-ol5]脑啡肽(DAMGO)镇咳作用的影响。[D-Ala2]强啡肽(3 nmol,脑室内注射)对咳嗽次数无显著影响。然而,在脑室内预先注射[D-Ala2]强啡肽II(3 nmol)后,DAMGO(0.03 nmol)的镇咳活性显著增强。选择性δ2-阿片受体拮抗剂纳曲吲哚的苯并呋喃衍生物(0.1 mg/kg,皮下注射)可阻止[D-Ala2]强啡肽II引起的DAMGO镇咳活性增强。这些结果表明,δ2-阿片受体可能在由μ-阿片受体介导的镇咳过程中发挥协同作用。